Assessment of oral zinc sulfate effect on the duration of treatment in children with acute gastroenteritis(GE) admitted in pediatrics ward

Assessment of oral zinc sulfate effect on the duration of treatment in children with acute gastroenteritis admitted in pediatrics ward

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT138902203900N1

Enrollment

400

Registered

2010-08-30

Start date

2007-04-10

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastroenteritis. Diarrhoea and gastroenteritis of presumed infectious origin

Interventions

Intervention 1: Control group: 5cc of dextrose water 5% as placebo, once daily. Intervention 2: Case group: 5cc of zinc sulfate (22 mg) once daily.

Placebo

Treatment - Drugs

Control group: 5cc of dextrose water 5% as placebo, once daily

Case group: 5cc of zinc sulfate (22 mg) once daily

Eligibility

Sex/Gender

All

Age

6 Years to 2 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: 6-24 months breast fed infants with mild to moderate dehydration with at least 2 days of gastroenteritis whose parents fill the consent form. Exclusion criteria: receiving complementary foods during last month and antibiotic during admission, severe FTT.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Improvement of symptoms. Timepoint: daily. Method of measurement: clinical assessment.	—

Secondary

Measure	Time frame
Weight gain. Timepoint: daily. Method of measurement: weight measurment with seca instrument.	—

Countries

Iran (Islamic Republic of)

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026